Dose-dense taxotere (T) and adriamycin/cyclophosphamide (AC) as neoadjuvant treatment in locally advanced breast cancer (LABC).

被引：0
|
作者：
García-Mata, J
Calvo, L
García-Palomo, A
Mel, JR
Almanza, MC
Ramos, M
de Paz, LH
机构：
[1] H Santa Maria Nai, Orense, Spain
[2] H Juan Canalejo, La Coruna, Spain
[3] H Leon, Leon, Spain
[4] H Xeral Calde, Lugo, Spain
[5] Clin Povisa, Vigo, Spain
[6] Ctr Oncol, La Coruna, Spain
[7] H Arquitecto Marcide, Ferrol, Spain
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S226 / S227
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety profile of the adriamycin/cyclophosphamide (AC) followed by docetaxel/cisplatin (DC) in locally advanced breast cancer
    Abdelhamid, T.
    Saber, M.
    Gaber, A. Abdel-Samie
    Selim, M.
    Youssef, O.
    Salama, A.
    Eldin, N. Aly
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [42] Comparison of Efficiency and Side Effect of Adriamycin and Doxetaxel and Adriamycin, Cyclophosphamide and Paclitaxel in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
    Hong, W.
    Kim, K.
    Jung, Y.
    Kim, J.
    Kang, S.
    Chun, J.
    Chun, M.
    Yim, H.
    Kang, D.
    Kim, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S172 - S173
  • [43] Neoadjuvant Dose-Dense and Dose-Intensified Chemotherapy in Breast Cancer - Review of the Literature
    Reinisch, Mattea
    Ataseven, Beyhan
    Kuemmel, Sherko
    [J]. BREAST CARE, 2016, 11 (01) : 13 - 20
  • [44] Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study (vol 18, pg 924, 2013)
    Clavarezza, Matteo
    Bordonaro, Roberto
    Daniele, Bruno
    Ferrandina, Gabriella
    Barni, Sandro
    Turazza, Monica
    Coati, Francesca
    De Matteis, Andrea
    De Placido, Sabino
    Cognetti, Francesco
    Olmeo, Nina Antonina
    Carrozza, Francesco
    Bruzzi, Paolo
    Del Mastro, Lucia
    [J]. ONCOLOGIST, 2013, 18 (10): : 1149 - 1149
  • [45] Clinical Advantages of Neoadjuvant Docetaxel (T) and Carboplatin (C) ± Trastuzumab (H) in Locally Advanced Breast Cancer (LABC)
    Chang, H. R.
    Glaspy, J.
    Gornbein, J.
    Kass, F. C.
    Allison, M. A.
    Chung, D. U.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 571S - 571S
  • [46] Neoadjuvant weekly carboplatin and paclitaxel followed by dose dense adriamycin/cyclophosphamide in locally advanced triple negative breast cancer: A single-center experience in a safety net hospital.
    Chen, Nan
    Bulsara, Shaun
    Hilsenbeck, Susan G.
    Rimawi, Mothaffar F.
    Nangia, Julie R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Primary dose-dense epirubicin/cyclophosphamide→docetaxel in breast cancer: preliminary results
    Cocciolone, V.
    Cannita, K.
    Bruera, G.
    Bafile, A.
    Coletti, G.
    Resta, V.
    Ciccozzi, A.
    Dalmas, A.
    Ficorella, C.
    Ricevuto, E.
    [J]. BREAST, 2015, 24 : S100 - S101
  • [48] Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
    Dang, Chau
    D'Andrea, Gabriella
    Lake, Diana
    Sugarman, Steve
    Fornier, Monica
    Moynahan, Mary Ellen
    Gilewski, Theresa
    Hurria, Arti
    Mills, Nancy
    Troso-Sandoval, Tiffany
    George, Roshini
    Robson, Mark
    Dickler, Maura
    Smith, Karen
    Panageas, Katherine S.
    Norton, Larry
    Hudis, Clifford A.
    [J]. CLINICAL BREAST CANCER, 2008, 8 (05) : 418 - 424
  • [49] Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Naruse, Saki
    Isono, Yuka
    Maeda, Yuka
    Sato, Ayana
    Yamada, Miki
    Ikeda, Tatsuhiko
    Sasajima, Yuko
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (12) : 1119 - 1124
  • [50] The cost-effectiveness of neoadjuvant chemotherapy in women with locally advanced breast cancer: Adriamycin and cyclophosphamide in comparison with paclitaxel and gemcitabine
    Javan-Noughabi, Javad
    Rezapour, Aziz
    Kassani, Aziz
    Hatam, Nahid
    Ahmadloo, Niloofar
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2018, 23
12345